Target Values and Daytime Variation of Bone Turnover Markers in Monitoring Osteoporosis Treatment After Fractures.

Borgen, Tove T; Solberg, Lene B; Lauritzen, Trine; Apalset, Ellen M; Bjørnerem, Åshild; Eriksen, Erik F

Borgen, Tove T; Solberg, Lene B; Lauritzen, Trine; Apalset, Ellen M; Bjørnerem, Åshild; Eriksen, Erik F.

Afiliación

Borgen TT; Department of Rheumatology Vestre Viken Hospital Trust, Drammen Hospital Drammen Norway.
Solberg LB; Division of Orthopedic Surgery Oslo University Hospital Oslo Norway.
Lauritzen T; Department of Laboratory Medicine Vestre Viken Hospital Trust, Drammen Hospital Drammen Norway.
Apalset EM; Department of Clinical Medicine University of Oslo Oslo Norway.
Bjørnerem Å; Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease, Department of Rheumatology Haukeland University Hospital Bergen Norway.
Eriksen EF; Department of Global Public Health and Primary Care University of Bergen Bergen Norway.

JBMR Plus ; 6(6): e10633, 2022 Jun.

Article en En | MEDLINE | ID: mdl-35720666

Palabras clave

ANTIRESORPTIVES; BIOCHEMICAL MARKERS OF BONE TURNOVER; DXA; FRACTURE RISK ASSESSMENT; OSTEOPOROSIS

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JBMR Plus Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google